Back to Search Start Over

Cardiovascular Safety and Efficacy of the PCSK9 Inhibitor Evolocumab in Diabetes and the Risk of Development of Diabetes: A Prespecified Analysis from the Randomized Controlled FOURIER Trial

Authors :
Sabatine, Ms
Leiter, La
Wiviott, Sd
Giugliano, Rp
Deedwania, P
DE FERRARI, GAETANO MARIA
Murphy, Sa
Kuder, Jf
Gouni-Berthold, J
Lewis, Bs
Handelsman, Y
Lira Pineda, A
Honarpour, N
Keech, Ac
Sever, Ps
Pedersen, Tr
Publication Year :
2017

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od.......970..d5d4fec49e0dd34ab7d0e92d811b5fa3

Tools

Authors Abstract Subjects Details